Are Physicians in Your Network Screening Patients With Diabetes for Kidney Disease?

Chronic kidney disease associated with type 2 diabetes may be progressing undetected

In a study that evaluated rates of kidney health screening 1 year prior to and 3 years after T2D diagnosis, 91% of patients with T2D were screened for kidney function using eGFR, but just 41% of patients received the recommended annual albuminuria (UACR) test for kidney damage.1,*

Download and share the resources below to increase awareness about appropriate screening among your network healthcare professionals.

Network Healthcare Professionals

Cardiorenal MR Overactivation Infographic

To provide awareness to payers, health systems, and physicians about the role of MR overactivation in CKD associated with T2D

Cardiorenal Connection Infographic

To describe the importance of early identification, as well as the association between CKD associated with T2D and cardiovascular- related complications and death

Cardiorenal Call-to-Action Infographic

Use this infographic to raise awareness about the prevalence, clinical burden, and appropriate screening parameters of CKD associated with T2D

Cardiorenal Early Detection and UACR Infographic

To communicate to payers, health systems, and physicians about the importance of early detection of CKD associated with T2D

Patient Resources

Disease State Awareness Infographic

Educate patients with type 2 diabetes about chronic kidney disease and the importance of kidney health screening (eg, UACR and eGFR assessment)

Doctor Discussion Guide

Provide this guide to patients to help them ask their providers insightful questions about kidney health

CKD Associated With T2D Patient Brochure

Give this brochure to patients to help them understand fast facts about the impact of CKD associated with T2D

Interested in finding out what other organizations are doing?

Learn More
  • As evidenced by a study that analyzed patients in the OPTUM electronic health record database who had an in-scope T2D diagnosis, were aged 18 years or older, had physician notes, were sourced from an integrated delivery network, and had 12 months pre- and 36 months post-index activity. 

Reference: 1. Data on file. Bayer.